Link to Home Page

Institute for Vaccine Safety

The Institute for Vaccine Safety was established in 1997 in the Department of International Health at the Johns Hopkins University School of Public Health - now the Johns Hopkins Bloomberg School of Public Health.

Our mission is to provide an independent assessment of vaccines and vaccine safety to help guide decision makers and educate physicians, the public and the media about key issues surrounding the safety of vaccines. The institute’s goal is to work toward preventing disease using the safest vaccines possible.


What's New on the IVS Website

  • Two new pages on COVID-19 Vaccines:
    • A page on What we know about COVID-19 Vaccine including background information, clinical trial data, safety information and links other information.
    • A table listing components of the two COVID-19 vaccines currently authorized for emergency use in the US. Anaphylaxis and other allergic reactions to these vaccines have been reported at a rate higher than for other vaccines. Polyethylene glycol is suspected as the allergen responsible for these reactions and there is cross reactivity with polysorbates which are present is some other vaccines.
  • The state of vaccine safety science: systematic review of the evidence. Dudley, et al, including other IVS faculty, update evidence assessing possible causal association of AEFIs.  Link to abstract
  • COVID-19: Information for Pediatric Healthcare Providers
    Link to CDC's information on Maintaining Childhood Immunizations During COVID-19 Pandemic
  • Prevent Shoulder Injury Associated with Vaccination (SIRVA)
    DO NOT try to identify the middle of the deltoid by using a fingerbreadth measurement from the acromion process. DO use the Australian method for identifying the middle of the deltoid injection site. Link to page
The information on this page was last updated on December 31, 2020 | © 2020 Institute for Vaccine Safety